Correction to: VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop.
Boudria A, Faycal CA, Jia T, Gout S, Keramidas M, Didier C, Lemaître N, Manet S, Coll JL, Toffart AC, Moro-Sibilot D, Albiges-Rizo C, Josserand V, Faurobert E, Brambilla C, Brambilla E, Gazzeri S, Eymin B.
Boudria A, et al. Among authors: eymin b.
Oncogene. 2023 Aug;42(32):2471-2472. doi: 10.1038/s41388-023-02764-w.
Oncogene. 2023.
PMID: 37407792
No abstract available.